Cited by 64Chromosomal and Genetic VariationsHIV Research and TreatmentVirus-based gene therapy research

Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K–Related Sequences

Open access
Contreras-Galindo, Rafael, Kaplan, Mark H., Dube, Derek, Gonzalez-Hernandez, Marta J., Chan, Susana, Meng, Fan, Dai, Manhong, Omenn, Gilbert S. +2 more·2015·Journal of Virology

Abstract

Human endogenous retroviruses (HERV) make up 8% of the human genome. While the youngest of these retroviruses, HERV-K(HML-2), termed HK2, is able to code for all viral proteins and produce virus-like particles, it is not known if these virus particles package and transmit HK2-related sequences. Here, we analyzed the capacity of HK2 for packaging and transmitting HK2 sequences. We created an HK2 probe, termed Bogota, which can be packaged into HK2 viruses, and transfected it into cells that make HK2 particles. Supernatants of the transfected cells, which contained HK2 viral particles, then were added to target cells, and the transmissibility of the HK2 Bogota reporter was tracked by G418 resistance. Our studies revealed that contemporary HK2 virions produced by some teratocarcinoma and breast cancer cell lines, as well as by peripheral blood lymphocytes from lymphoma patients, can package HK2 Bogota probes, and these viruses transmitted these probes to other cells. After transmission, HK2 Bogota transcripts undergo reverse transcription, a step impaired by antiretroviral agents or by introduction of mutations into the probe sequences required for reverse transcription. HK2 viruses were more efficiently transmitted in the presence of HK2 Rec or HIV-1 Tat and Vif. Transmitted Bogota probes formed episomes but did not integrate into the cellular genome. Resistance to integration might explain the relatively low number of HK2 insertions that were acquired during the last 25 million years of evolution. Whether transient transmission of modern HK2 sequences, which encode two putative oncoproteins, can lead to disease remains to be studied. IMPORTANCE Retroviruses invaded the genome of human ancestors over the course of millions of years, yet these viruses generally have been inactivated during evolution, with only remnants of these infectious sequences remaining in the human genome. One of these viruses, termed HK2, still is capable of producing virus particles, although these particles have been regarded as being noninfectious. Using a genetic probe derived from HK2, we have discovered that HK2 viruses produced in modern humans can package HK2 sequences and transmit them to various other cells. Furthermore, the genetic sequences packaged in HK2 undergo reverse transcription. The transmitted probe circularized in the cell and failed to integrate into the cellular genome. These findings suggest that modern HK2 viruses can package viral RNA and transmit it to other cells. Contrary to previous views, we provide evidence of an extracellular viral phase of modern HK2 viruses. We have no evidence of sustained, spreading infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.00544-15

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Engineered recombinant HERV-K constructs that contain all open reading frames are capable of viral transmission in cell culture.

    “Engineered recombinant HERV-K constructs that contain all open reading frames are capable of viral transmission in cell culture”

    From The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders (2024) · cites this paper as Contreras-Galindo et al. 2015

    Materials and Methods describes an infectious engineered HERV-KCON construct, and the Results (Fig. 4B caption) uses its infectivity in 293T cells as a positive control for transmission. The copy does not establish that the transmitted construct retained all open reading frames: it describes a reporter inserted into env and VSV-G-pseudotyped virions. The Bogota reporter used in the main transmission experiments had its retroviral genes replaced. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • There is no fully functional HERV-K in the human genome, but a number of HERV-K proviruses are capable of making one or several of the viral proteins.

    “There is no fully functional HERV-K in the human genome, but a number of HERV-K proviruses are capable of making one or several of the viral proteins”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 73

  1. [1]1. Jern P, Coffin JM. 2008. Effects of retroviruses on host genome function. Annu Rev Genet 42: 709-732. http://dx.doi.org/10.1146/annurev.genet .42.110807.091501. · DOI
  2. [2]2. Nelson PN, Carnegie PR, Martin J, Davari Ejtehadi H, Hooley P, Roden D, Rowland-Jones S, Warren P, Astley J, Murray PG. 2003. Demystified. Human endogenous retroviruses. Mol Pathol 56: 11-18. http://dx.doi.org/10.1136/mp.56.1.11. · DOI
  3. [3]3. Subramanian RP, Wildschutte JH, Russo C, Coffin JM. 2011. Identification, characterization, and comparative genomic distribution of the HK2groupofhumanendogenousretroviruses. Retrovirology 8: 90. http: //dx.doi.org/10.1186/1742-4690-8-90. · DOI · Paper page
  4. [5]5. Okahara G, Matsubara S, Oda T, Sugimoto J, Jinno Y, Kanaya F. 2004. Expression analyses of human endogenous retroviruses (HERVs): tissuespecific and developmental stage-dependent expression of HERVs. Genomics 84: 982-990. http://dx.doi.org/10.1016/j.ygeno.2004.09.004. · DOI
  5. [6]6. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M. 2004. Long-term reinfection of the human genome by endogenous retroviruses. Proc Natl Acad Sci U S A 101: 4894-4899. http: //dx.doi.org/10.1073/pnas.0307800101. · DOI
  6. [7]7. Paces J, Pavlícek A, Zika R, Kapitonov VV, Jurka J, Paces V. 2004. HERVd: the Human Endogenous RetroViruses Database: update. Nucleic Acids Res 32: D50. http://dx.doi.org/10.1093/nar/gkh075. · DOI
  7. [8]8. Hughes JF, Coffin JM. 2004. Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc Natl Acad Sci U S A 101: 1668-1672. http://dx.doi .org/10.1073/pnas.0307885100. · DOI
  8. [9]9. Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, GonzalezHernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM. 2012. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. J Virol 86: 262-276. http://dx.doi.org/10.1128/JVI.00602-11. · DOI · Paper page
  9. [10]10. Contreras-Galindo R, Kaplan MH, He S, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Kappes F, Dube D, Chan SM, Robinson D, Meng F, Dai M, Gitlin SD, Chinnaiyan AM, Omenn GS, Markovitz DM. 2013. HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses. Genome Res 23: 1505-1513. http://dx.doi.org/10.1101/gr.144303.112. · DOI
  10. [11]11. Hughes JF, Coffin JM. 2005. Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome. Genetics 171: 1183-1194. http://dx.doi.org/10.1534/genetics.105.043976. · DOI · Paper page
  11. [12]12. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. 2001. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 11: 1531-1535. http://dx.doi.org/10.1016/S0960 -9822(01)00455-9. · DOI
  12. [13]13. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. 2001. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 50: 434-442. http://dx.doi.org/10.1002/ana.1131. · DOI · Paper page
  13. [14]14. Ruda VM, Akopov SB, Trubetskoy DO, Manuylov NL, Vetchinova AS, Zavalova LL, Nikolaev LG, Sverdlov ED. 2004. Tissue specificity of enhancer and promoter activities of a HERV-K(HML-2) LTR. Virus Res 104: 11-16. http://dx.doi.org/10.1016/j.virusres.2004.02.036. · DOI
  14. [16]16. Sugimoto J, Matsuura N, Kinjo Y, Takasu N, Oda T, Jinno Y. 2001. Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. Genomics 72: 137-144. http://dx.doi.org/10 .1006/geno.2001.6473.
  15. [24]24. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. 2006. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res Hum Retrovir 22: 979-984. http://dx.doi.org/10.1089/aid.2006.22.979. · DOI
  16. [25]25. Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM. 2008. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 82: 9329-9336. http: //dx.doi.org/10.1128/JVI.00646-08. · DOI
  17. [26]26. Contreras-Galindo R, Almodóvar-Camacho S, González-Ramírez S, Lorenzo E, Yamamura Y. 2007. Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res Hum Retrovir 23: 1083-1086. http://dx.doi.org/10.1089/aid.2007 .0054. · DOI
  18. [27]27. Contreras-Galindo R, López P, Vélez R, Yamamura Y. 2007. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retrovir 23: 116-122. http: //dx.doi.org/10.1089/aid.2006.0117. · DOI
  19. [28]28. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. 1999. An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet 21: 257-258. http://dx.doi.org/10.1038/6766. · DOI
  20. [32]32. Ruprecht K, Ferreira H, Flockerzi A, Wahl S, Sauter M, Mayer J, Mueller-Lantzsch N. 2008. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21. J Virol 82: 10008-10016. http://dx.doi.org/10.1128/JVI.01016-08. · DOI
  21. [34]34. Heslin DJ, Murcia P, Arnaud F, Van Doorslaer K, Palmarini M, Lenz J. 2009. A single amino acid substitution in a segment of the CA protein within Gag that has similarity to human immunodeficiency virus type 1 blocks infectivity of a human endogenous retrovirus K provirus in the human genome. J Virol 83: 1105-1114. http://dx.doi.org/10.1128/JVI .01439-08. · DOI
  22. [35]35. Kraus B, Boller K, Reuter A, Schnierle BS. 2011. Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites. Retrovirology 8: 21. http://dx.doi.org/10.1186/1742-4690 -8-21. · DOI
  23. [36]36. George M, Schwecke T, Beimforde N, Hohn O, Chudak C, Zimmermann A, Kurth R, Naumann D, Bannert N. 2011. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERVK(HML-2) element. Retrovirology 8: 30. http://dx.doi.org/10.1186/1742 -4690-8-30. · DOI
  24. [37]37. Kuhelj R, Rizzo CJ, Chang CH, Jadhav PK, Towler EM, Korant BD. 2001. Inhibition of human endogenous retrovirus-K10 protease in cellfree and cell-based assays. J Biol Chem 276: 16674-16682. http://dx.doi .org/10.1074/jbc.M008763200. · DOI
  25. [39]39. Tönjes RR, Boller K, Limbach C, Lugert R, Kurth R. 1997. Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology 233: 280-291. http: //dx.doi.org/10.1006/viro.1997.8614. · DOI
  26. [41]41. Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, Tsarfaty I. 2008. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia 10: 521533. http://dx.doi.org/10.1593/neo.07986. · DOI
  27. [44]44. Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. 1999. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A 96: 13404-13408. http://dx.doi.org/10.1073/pnas.96.23.13404. · DOI
  28. [46]46. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M. 2005. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol 22: 814817. http://dx.doi.org/10.1093/molbev/msi088. · DOI
  29. [47]47. Stoye JP. 2001. Endogenous retroviruses: still active after all these years? Curr Biol 11: R914-R916. http://dx.doi.org/10.1016/S0960 -9822(01)00553-X. · DOI
  30. [48]48. Magiorkinis G, Belshaw R, Katzourakis A. 2013. 'There and back again': revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era. Philos Trans R Soc Lond B Biol Sci 368: 20120504. http://dx.doi.org/10.1098/rstb.2012.0504. · DOI
  31. [49]49. Ribet D, Dewannieux M, Heidmann T. 2004. An active murine transposon family pair: retrotransposition of 'master' MusD copies and ETn trans-mobilization. Genome Res 14: 2261-2267. http://dx.doi.org/10 .1101/gr.2924904.
  32. [50]50. Evans LH, Alamgir AS, Owens N, Weber N, Virtaneva K, Barbian K, Babar A, Malik F, Rosenke K. 2009. Mobilization of endogenous retroviruses in mice after infection with an exogenous retrovirus. J Virol 83: 2429-2435. http://dx.doi.org/10.1128/JVI.01926-08. · DOI
  33. [52]52. Lee YN, Bieniasz PD. 2007. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 3: e10. http://dx.doi.org/10.1371 /journal.ppat.0030010.
  34. [53]53. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, Heidmann T. 2006. Identification of an infectious progenitor for the multiple-copy HERV-K humanendogenousretroelements. Genome Res 16: 1548-1556. http://dx.doi.org/10.1101/gr.5565706. · DOI · Paper page
  35. [54]54. Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM. 2014. Genomic flexibility of human endogenous retrovirus type K. J Virol 88: 9673-9682. http://dx .doi.org/10.1128/JVI.01147-14. · DOI
  36. [55]55. Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian, HH, Jr. 1996. High frequency retrotransposition in cultured mammalian cells. Cell 87: 917-927. http://dx.doi.org/10.1016 /S0092-8674(00)81998-4.
  37. [56]56. Moran JV, DeBerardinis RJ, Kazazian, HH, Jr. 1999. Exon shuffling by L1 retrotransposition. Science 283: 1530-1534. http://dx.doi.org/10 .1126/science.283.5407.1530.
  38. [57]57. Gilbert N, Lutz-Prigge S, Moran JV. 2002. Genomic deletions created upon LINE-1 retrotransposition. Cell 110: 315-325. http://dx.doi.org/10 .1016/S0092-8674(02)00828-0.
  39. [58]58. Garcia-Perez JL, Marchetto MC, Muotri AR, Coufal NG, Gage FH, O'Shea KS, Moran JV. 2007. LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet 16: 1569-1577. http://dx.doi.org/10 .1093/hmg/ddm105.
  40. [59]59. Brady T, Lee YN, Ronen K, Malani N, Berry CC, Bieniasz PD, Bushman FD. 2009. Integration target site selection by a resurrected humanendogenousretrovirus. Genes Dev 23: 633-642. http://dx.doi.org /10.1101/gad.1762309. · DOI
  41. [60]60. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, Lovci MT, Morell M, O'Shea KS, Moran JV, Gage FH. 2009. LINE-1 retrotransposition in human neural progenitor cells. Nature 460: 1127-1131. http: //dx.doi.org/10.1038/nature08248. · DOI · Paper page
  42. [61]61. Nelson DL, Ledbetter SA, Corbo L, Victoria MF, Ramírez-Solis R, Webster TD, Ledbetter DH, Caskey CT. 1989. Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci U S A 86: 6686-6690. http: //dx.doi.org/10.1073/pnas.86.17.6686. · DOI
  43. [62]62. Gentile A, D'Alessandro L, Lazzari L, Martinoglio B, Bertotti A, Mira A, Lanzetti L, Comoglio PM, Medico E. 2008. Met-driven invasive growth involves transcriptional regulation of Arhgap12. Oncogene 27: 5590-5598. http://dx.doi.org/10.1038/onc.2008.173. · DOI
  44. [63]63. Badge RM, Alisch RS, Moran JV. 2003. ATLAS: a system to selectively identify human-specific L1 insertions. Am J Hum Genet 72: 823-838. http://dx.doi.org/10.1086/373939. · DOI
  45. [64]64. Felsenstein J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39: 783-791. http://dx.doi.org/10.2307 /2408678.
  46. [65]65. Hills D, Bull J. 1993. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol 42: 182-192. http: //dx.doi.org/10.1093/sysbio/42.2.182. · DOI
  47. [66]66. Etherington GJ, Dicks J, Roberts IN. 2005. Recombination Analysis Tool (RAT): a program for the high-throughput detection of recombination. Bioinformatics 21: 278-281. http://dx.doi.org/10.1093 /bioinformatics/bth500.
  48. [67]67. Lavie L, Kitova M, Maldener E, Meese E, Mayer J. 2005. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol 79: 876-883. http://dx .doi.org/10.1128/JVI.79.2.876-883.2005. · DOI
  49. [68]68. Flockerzi A, Maydt J, Frank O, Ruggieri A, Maldener E, Seifarth W, Medstrand P, Lengauer T, Meyerhans A, Leib-Mösch C, Meese E, Mayer J. 2007. Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination. Retrovirology 4: 39. http://dx.doi.org/10.1186/1742-4690-4-39. · DOI
  50. [72]72. Onafuwa-Nuga AA, King SR, Telesnitsky A. 2005. Nonrandom packaging of host RNAs in Moloney murine leukemia virus. J Virol 79: 13528-13537. http://dx.doi.org/10.1128/JVI.79.21.13528-13537.2005. · DOI
  51. [73]73. Onafuwa-Nuga AA, Telesnitsky A, King SR. 2006. 7SL RNA, but not the 54-kd signal recognition particle protein, is an abundant component of both infectious HIV-1 and minimal virus-like particles. RNA 12: 542546. http://dx.doi.org/10.1261/rna.2306306. · DOI
  52. [74]74. Muriaux D, Mirro J, Harvin D, Rein A. 2001. RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A 98: 5246-5251. http://dx.doi.org/10.1073/pnas.091000398. · DOI
  53. [76]76. Rulli SJ, Jr, Hibbert CS, Mirro J, Pederson T, Biswal S, Rein A. 2007. Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol 81: 6623-6631. http://dx.doi.org/10.1128/JVI.02833-06. · DOI · Paper page
  54. [78]78. Jouvenet N, Lainé S, Pessel-Vivares L, Mougel M. 2011. Cell biology of retroviral RNA packaging. RNA Biol 8: 572-580. http://dx.doi.org/10 .4161/rna.8.4.16030.
  55. [79]79. Rosenblum LL, Patton G, Grigg AR, Frater AJ, Cain D, Erlwein O, Hill CL, Clarke JR, McClure MO. 2001. Differential susceptibility of retroviruses to nucleoside analogues. Antivir Chem Chemother 12: 91-97. http://dx.doi.org/10.1177/095632020101200202. · DOI
  56. [80]80. Coffin JM, Hughes SH, Varmus HE (ed). 1997. Retroviruses. Overview of Reverse Transcription. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  57. [81]81. Sharkey ME, Stevenson M. 2001. Two long terminal repeat circles and persistent HIV-1 replication. Curr Opin Infect Dis 14: 5-11. http://dx.doi .org/10.1097/00001432-200102000-00002. · DOI
  58. [82]82. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF. 2002. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 76: 4138-4144. http://dx.doi.org /10.1128/JVI.76.8.4138-4144.2002. · DOI
  59. [83]83. Sloan RD, Wainberg MA. 2011. The role of unintegrated DNA in HIV infection. Retrovirology 8: 52. http://dx.doi.org/10.1186/1742 -4690-8-52. · DOI
  60. [84]84. Ejthadi HD, Martin JH, Junying J, Roden DA, Lahiri M, Warren P, Murray PG, Nelson PN. 2005. A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer. Arch Virol 150: 177-184. http://dx.doi.org/10.1007/s00705-004-0378-8. · DOI
  61. [85]85. Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ, Jr, Kaplan MH, Markovitz DM. 2012. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol 86: 7790-7805. http://dx.doi .org/10.1128/JVI.07215-11. · DOI
  62. [22]22. R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM. 2014. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein. J Virol 88: 8924-8935. http://dx.doi.org/10.1128/JVI.00556-14. · DOI
  63. [87]87. Lokossou AG, Toudic C, Barbeau B. 2014. Implication of human endogenous retrovirus envelope proteins in placental functions. Viruses 6: 4609-4627. http://dx.doi.org/10.3390/v6114609. · DOI
  64. [89]89. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809. http://dx .doi.org/10.1016/S0092-8674(03)00423-9. · DOI
  65. [90]90. Lecossier D, Bouchonnet F, Clavel F, Hance AJ. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300: 1112. http: //dx.doi.org/10.1126/science.1083338. · DOI
  66. [91]91. Armitage AE, Katzourakis A, de Oliveira T, Welch JJ, Belshaw R, Bishop KN, Kramer B, McMichael AJ, Rambaut A, Iversen AK. 2008. Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERVK(HML2) sequences. J Virol 82: 8743-8761. http://dx.doi.org/10.1128 /JVI.00584-08.
  67. [92]92. Bhardwaj N, Maldarelli F, Mellors J, Coffin JM. 2014. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. J Virol 88: 11108-11120. http://dx.doi.org/10.1128/JVI .01623-14. · DOI
  68. [93]93. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, RakoffNahoum S, Lenz J, Ostrowski MA, Nixon DF. 2007. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 3: e165. http://dx.doi.org/10.1371/journal.ppat.0030165. · DOI · Paper page
  69. [94]94. Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF. 2011. Identification of human endogenous retrovirus (HERV)-specific T cell responses in vertically HIV-1-infected subjects. J Virol 85: 11526-11531. http://dx.doi.org/10.1128/JVI.05418-11. · DOI
  70. [95]95. Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, Rieger M, Muscat-King S, Loudon PT, Stanley C, Holditch SJ, Wong JC, Clayton K, Duan E, Song H, Xu Y, SenGupta D, Tandon R, Sacha JB, Brockman MA, Benko E, Kovacs C, Nixon DF, Ostrowski MA. 2012. HERV-K-specific Tcells eliminate diverse HIV-1/2 and SIV primary isolates. J Clin Investig 122: 4473-4489. http://dx.doi.org/10.1172/JCI64560. · DOI
  71. [97]97. Piechaczek C, Fetzer C, Baiker A, Bode J, Lipps HJ. 1999. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 27: 426-428. http://dx .doi.org/10.1093/nar/27.2.426. · DOI
  72. [98]98. Glover DJ, Lipps HJ, Jans DA. 2005. Towards safe, non-viral therapeutic gene expression in humans. Nat Rev Genet 6: 299-310. http://dx.doi .org/10.1038/nrg1577. · DOI
  73. [100]100. Brinzevich D, Young GR, Sebra R, Ayllon J, Maio SM, Deikus G, Chen BK, Fernandez-Sesma A, Simon V, Mulder LC. 2014. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes. J Virol 88: 6213-6223. http://dx.doi.org /10.1128/JVI.00669-14. · DOI

Cited by

Sorted by citations

Authors
Contreras-Galindo, R., Kaplan, M. H., Dube, D., Gonzalez-Hernandez, M. J., Chan, S., Meng, F., Dai, M., Omenn, G. S., Gitlin, S. D., & Markovitz, D. M.
Affiliations
University of Michigan (US)
Venue
Journal of Virology
Published
2015-07-15
Volume
89
Issue
14
Pages
7187-7201
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2162245989
Cited by
64
References
8
Citations by year
2026: 4 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 5 · 2021: 3 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 6 · 2015: 5
FWCI
7.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Michigan
  • National Institutes of Health (RM-08-029)
  • National Institute on Drug Abuse (U54DA021519)
  • National Cancer Institute (K22CA177824, R01CA144043, F31CA150523)
  • National Institute of General Medical Sciences (T32GM007315, T32GM145304)
  • National Institute of Allergy and Infectious Diseases (T32AI007528, F32AI106189)
  • National Institute of Environmental Health Sciences (P30 U54ES017885, P30ES017885)
  • National Center for Research Resources (UL1RR024986, UL1 RR24986)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Chromosomal and Genetic Variations
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HERV-K, HERV-K(HML-2), HK2, virus-like particles, virus transmission, reverse transcription, episomes, retroviral integration, HIV-1 Tat protein, HIV-1 Vif, oncoprotein, retroviral evolution, teratocarcinoma cells, breast cancer cells, lymphoma cells
MeSH terms
Cell Line, DNA, Viral, Humans, Transcription, Genetic, Transduction, Genetic, Genes, Reporter, Virus Assembly, Endogenous Retroviruses, Gene Transfer, Horizontal, Reverse Transcription

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review